Evidence map›Paper›PMID 31205685›Full record

ArticleCell regeneration (London, England)2019

Nuclear-cytoplasmic shuttling of class IIa histone deacetylases regulates somatic cell reprogramming.

Zhiwei Luo, Xiaobing Qing, Christina Benda, Zhijian Huang, Meng Zhang, Yinghua Huang, Hui Zhang, Lulu Wang, Yiwei Lai, Carl Ward and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Cell regeneration (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Welcome to Cell Regeneration.Cell regeneration (London, England) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Zhiwei LuoKey Laboratory of Regenerative Biology.
Xiaobing QingLaboratory of RNA, Chromatin, and Human Disease.
Christina BendaLaboratory of RNA, Chromatin, and Human Disease.
Zhijian HuangLaboratory of RNA, Chromatin, and Human Disease.
Meng ZhangKey Laboratory of Regenerative Biology.
Yinghua HuangKey Laboratory of Regenerative Biology.
Hui ZhangKey Laboratory of Regenerative Biology.
Lulu WangKey Laboratory of Regenerative Biology.
Yiwei LaiKey Laboratory of Regenerative Biology.
Carl WardKey Laboratory of Regenerative Biology.
Giacomo VolpeKey Laboratory of Regenerative Biology.
Xiaofen ZhongKey Laboratory of Regenerative Biology.
Baoming QinKey Laboratory of Regenerative Biology.
Qiang ZhuangLaboratory of RNA, Chromatin, and Human Disease.
Miguel A EstebanKey Laboratory of Regenerative Biology.
Wenjuan LiJoint School of Life Sciences, Guangzhou Medical University and Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 511436, China.
Regenerative Medicine Institute · MXChinese Academy of Sciences · CNGuangzhou Institutes of Biomedicine and Health · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Class IIa histone deacetylases (HDACs) are a subfamily of HDACs with important functions in development and adult tissue homeostasis. As opposed to other HDACs, they lack catalytic function and bind transcription factors to recruit transcriptional co-regulators, mostly co-repressors such as nuclear receptor co-repressor (NCoR)/silencing mediator of retinoid and thyroid hormone receptor (SMRT). Class IIa HDACs enhance mouse somatic cell reprogramming to induced pluripotent stem cells (iPSCs) by repressing the function of the pro-mesenchymal transcription factor myocyte enhancer factor 2 (MEF2), which is upregulated during this process. Here, we describe, using HDAC4 and 7 as examples, that class IIa HDACs exhibit nuclear-cytoplasmic trafficking in reprogramming, being mostly cytoplasmic in donor fibroblasts and intermediate cells but translocating to the nucleus in iPSCs. Importantly, over-expressing a mutant form of HDAC4 or 7 that becomes trapped in the nucleus enhances the early phase of reprogramming but is deleterious afterwards. The latter effect is mediated through binding to the exogenous reprogramming factors at pluripotency loci, and the subsequent recruitment of NCoR/SMRT co-repressors. Thus, our findings uncover a context-dependent function of class IIa HDACs in reprogramming and further reinforce the idea that recruitment of co-repressors by the exogenous factors is a major obstacle for reactivating the pluripotency network in this process.

Indexed as

Class IIa HDACsiPSCsMesenchymal-to-epithelial transitionNCoR/SMRT co-repressorsPluripotencySomatic cell reprogramming

Identifiers

PMID31205685
PMCPMC6557759
OpenAlexW2914994480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.